Kwitniewski Mateusz, Juzeniene Asta, Ma Li-Wei, Glosnicka Renata, Graczyk Alfreda, Moan Johan
Department of Molecular Microbiology and Serology, National Salmonella Centre, Medical University of Gdansk, ul. Do Studzienki 38, 80-227 Gdansk, Poland.
J Photochem Photobiol B. 2009 Mar 3;94(3):214-22. doi: 10.1016/j.jphotobiol.2008.11.005. Epub 2008 Nov 30.
Photodynamic therapy (PDT) is an alternative treatment modality involving light activated drugs, called photosensitizers (PSs), to treat cancer and non-cancerous conditions. The search for new compounds which might become effective PSs is the major direction for PDT development. In the present work we have studied the dark toxicity, intracellular localization and photodynamic properties of four potential, water soluble, second generation PSs--PP(Arg)(2), PP(Ser)(2)Arg(2), PP(Ala)(2)Arg(2), PP(Phe)(2)Arg(2), all diamino acid derivatives of protoporphyrin IX. Human prostate cancer (DU-145) and squamous carcinoma (A431) cells were used as experimental model. Among investigated compounds PP(Ser)(2)Arg(2) exhibited the lowest dark toxicity and the highest PDT effectiveness towards both cell lines. Fluorescence microscopy revealed the time-dependent changes in intracellular localization of the PS which were related to the phototoxicity. The results show that PP(Ser)(2)Arg(2) may be a potential PS for PDT.
光动力疗法(PDT)是一种替代治疗方式,涉及光激活药物,即光敏剂(PSs),用于治疗癌症和非癌性疾病。寻找可能成为有效光敏剂的新化合物是光动力疗法发展的主要方向。在本研究中,我们研究了四种潜在的水溶性第二代光敏剂——PP(Arg)(2)、PP(Ser)(2)Arg(2)、PP(Ala)(2)Arg(2)、PP(Phe)(2)Arg(2)(均为原卟啉IX的二氨基酸衍生物)的暗毒性、细胞内定位和光动力性质。以人前列腺癌(DU - 145)细胞和鳞状细胞癌(A431)细胞作为实验模型。在所研究的化合物中,PP(Ser)(2)Arg(2)对两种细胞系均表现出最低的暗毒性和最高的光动力疗法有效性。荧光显微镜检查揭示了光敏剂细胞内定位随时间的变化,这些变化与光毒性相关。结果表明,PP(Ser)(2)Arg(2)可能是一种用于光动力疗法的潜在光敏剂。